Avac Event

Webinar: Building on (and Building!) Success—Status of HVTN 702 with Fatima Laher

Dr. Fatima Laher, protocol co-chair of HVTN 702, provides an overview of the first HIV vaccine efficacy trial in seven years. Her presentation looks at the history, starting with partial success of RV144 in 2009, and talks about the role HVTN 702 as the field advances toward an effective vaccine.

Recording: YouTube / Audio / Slides

This was one in a series of HIV Vaccine Awareness Day webinars. For details on all other calls, including recordings, visit here.